Search research articles
Contact Us
Filters
Showing results (1-10 of 66) with videos related to
Page
of 7
Sort By:
Military Medicine
|
May 22, 2010
A suicide prevention advisory group at an academic medical center
David Hough, Philip Lewis
Hepatology (Baltimore, Md.)
|
January 29, 2011
Hepatocyte-specific magnetic resonance imaging contrast agents
Jeff Fidler, David Hough
The Laryngoscope
|
September 30, 2004
Amplitude effects on electrocochleography outcomes
David Hough, R Stanley Baker
Schizophrenia Research
|
March 27, 2012
Treatment response after relapse in a placebo-controlled maintenance trial in schizophrenia
Robin Emsley, Isaac Nuamah, David Hough, et al.
Innovations in Clinical Neuroscience
|
April 5, 2013
Regarding "A Risperidone-induced Prolactinoma Resolved When A Woman with Schizoaffective Disorder Switched to Ziprasidone: A Case Report"
Danielle Coppola, Shanker Thiagarajah, Hong Qiu, et al.
Journal of Affective Disorders
|
July 14, 2010
Evaluation of the efficacy and safety of paliperidone extended-release in the treatment of acute mania: a randomized, double-blind, dose-response study
Joris Berwaerts, Haiyan Xu, Isaac Nuamah, et al.
Journal of Clinical Psychopharmacology
|
November 3, 2016
Paliperidone Palmitate Long-Acting Injectable Given Intramuscularly in the Deltoid Versus the Gluteal Muscle: Are They Therapeutically Equivalent?
Paulien Ravenstijn, Mahesh Samtani, Alberto Russu, et al.
Biological Psychiatry
|
August 12, 2011
A randomized, double-blind study of paliperidone extended-release in treatment of acute schizophrenia in adolescents
Jaskaran Singh, Adelaide Robb, Ujjwala Vijapurkar, et al.
Gene
|
December 25, 2003
An rxr/usp homolog from the parasitic nematode, Dirofilaria immitis
Cathy Shea, David Hough, Jianping Xiao, et al.
Journal of the American Academy of Child and Adolescent Psychiatry
|
January 25, 2015
Efficacy and safety of paliperidone extended release in adolescents with schizophrenia: a randomized, double-blind study
Adam J Savitz, Rosanne Lane, Isaac Nuamah, et al.
Page
of 7
Search research articles
Search
Showing results (1-10 of 66) with videos related to
Sort By:
Page
of 7
Military Medicine
|
May 22, 2010
A suicide prevention advisory group at an academic medical center
David Hough, Philip Lewis
Hepatology (Baltimore, Md.)
|
January 29, 2011
Hepatocyte-specific magnetic resonance imaging contrast agents
Jeff Fidler, David Hough
The Laryngoscope
|
September 30, 2004
Amplitude effects on electrocochleography outcomes
David Hough, R Stanley Baker
Schizophrenia Research
|
March 27, 2012
Treatment response after relapse in a placebo-controlled maintenance trial in schizophrenia
Robin Emsley, Isaac Nuamah, David Hough, et al.
Innovations in Clinical Neuroscience
|
April 5, 2013
Regarding "A Risperidone-induced Prolactinoma Resolved When A Woman with Schizoaffective Disorder Switched to Ziprasidone: A Case Report"
Danielle Coppola, Shanker Thiagarajah, Hong Qiu, et al.
Journal of Affective Disorders
|
July 14, 2010
Evaluation of the efficacy and safety of paliperidone extended-release in the treatment of acute mania: a randomized, double-blind, dose-response study
Joris Berwaerts, Haiyan Xu, Isaac Nuamah, et al.
Journal of Clinical Psychopharmacology
|
November 3, 2016
Paliperidone Palmitate Long-Acting Injectable Given Intramuscularly in the Deltoid Versus the Gluteal Muscle: Are They Therapeutically Equivalent?
Paulien Ravenstijn, Mahesh Samtani, Alberto Russu, et al.
Biological Psychiatry
|
August 12, 2011
A randomized, double-blind study of paliperidone extended-release in treatment of acute schizophrenia in adolescents
Jaskaran Singh, Adelaide Robb, Ujjwala Vijapurkar, et al.
Gene
|
December 25, 2003
An rxr/usp homolog from the parasitic nematode, Dirofilaria immitis
Cathy Shea, David Hough, Jianping Xiao, et al.
Journal of the American Academy of Child and Adolescent Psychiatry
|
January 25, 2015
Efficacy and safety of paliperidone extended release in adolescents with schizophrenia: a randomized, double-blind study
Adam J Savitz, Rosanne Lane, Isaac Nuamah, et al.
Page
of 7